| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Are Manufacturing Patents to Blame for Biosimilar Market Launch Delays?
|
Williamson, Rhys
|
|
|
27 |
3 |
p. 287-293
|
artikel
|
| 2 |
Drug Pricing, Patient Welfare, and Cost-Effectiveness Analysis
|
van Baal, Pieter
|
|
|
27 |
3 |
p. 271-272
|
artikel
|
| 3 |
Editorial Board
|
|
|
|
27 |
3 |
p. iv
|
artikel
|
| 4 |
Financial Characteristics of Outcomes-Based Agreements: What Do Canadian Public Payers and Pharmaceutical Manufacturers Prefer?
|
Wills, Allison
|
|
|
27 |
3 |
p. 340-346
|
artikel
|
| 5 |
Identifying the Optimum Strategy for Identifying Adults and Children With Celiac Disease: A Cost-Effectiveness and Value of Information Analysis
|
Keeney, Edna
|
|
|
27 |
3 |
p. 301-312
|
artikel
|
| 6 |
Logical Inconsistencies in the Health Years in Total and Equal Value of Life-Years Gained
|
Paulden, Mike
|
|
|
27 |
3 |
p. 356-366
|
artikel
|
| 7 |
Modeling Thyroid Cancer Epidemiology in the United States Using Papillary Thyroid Carcinoma Microsimulation Model
|
Alagoz, Oguzhan
|
|
|
27 |
3 |
p. 367-375
|
artikel
|
| 8 |
Opportunities and Challenges for Decentralized Clinical Trial Approaches: European Health Technology Assessment Perspective
|
de Jong, Amos J.
|
|
|
27 |
3 |
p. 294-300
|
artikel
|
| 9 |
Patient Welfare Implications of Indication-Specific Value-Based Pricing of Multi-Indication Drugs
|
Jiang, Yawen
|
|
|
27 |
3 |
p. 273-277
|
artikel
|
| 10 |
Perils of Randomized Controlled Trial Survival Extrapolation Assuming Treatment Effect Waning: Why the Distinction Between Marginal and Conditional Estimates Matters
|
Jennings, Angus C.
|
|
|
27 |
3 |
p. 347-355
|
artikel
|
| 11 |
Quantifying the Value of Reduced Health Disparities: Low-Dose Computed Tomography Lung Cancer Screening of High-Risk Individuals Within the United States
|
Shafrin, Jason
|
|
|
27 |
3 |
p. 313-321
|
artikel
|
| 12 |
Scoring the Value Assessment Framework for China: A Factorial Survey
|
Zhang, Mengmeng
|
|
|
27 |
3 |
p. 330-339
|
artikel
|
| 13 |
Table of Contents
|
|
|
|
27 |
3 |
p. i-iii
|
artikel
|
| 14 |
Unanchored Population-Adjusted Indirect Comparison Methods for Time-to-Event Outcomes Using Inverse Odds Weighting, Regression Adjustment, and Doubly Robust Methods With Either Individual Patient or Aggregate Data
|
Park, Julie E.
|
|
|
27 |
3 |
p. 278-286
|
artikel
|
| 15 |
Using the Online Elicitation of Personal Utility Functions Approach to Derive a Patient-Based 5-Level Version of EQ-5D Value Set: A Study in 122 Patients With Rheumatic Diseases From Germany
|
Schneider, Paul
|
|
|
27 |
3 |
p. 376-382
|
artikel
|
| 16 |
Work Productivity Among Younger Breast Cancer Survivors: The Impact of Behavioral Interventions for Depression
|
Crespi, Catherine M.
|
|
|
27 |
3 |
p. 322-329
|
artikel
|
Tijdschrift beschrijving